Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Carotid StenosisBrain IschemiaLaboratory Problem
Interventions
PROCEDURE

Carotid stenting

Procedures will be carried out via the femoral approach following a Seldinger technique. All patients will be on long-term aspirin (100 mg/day) and a 525-mg loading dose of clopidogrel. A dose of 10 000 units unfractionated heparin will be administered at the beginning of the intervention. A cerebral protection device (FilterWire EZ™; Boston Scientific, Natick, Massachusetts, USA) will be use in all patients if possible. The type of covered stent and other specific intervention strategies will be left to the discretion of the interventional radiologists. After predilatation of the stenosis (if needed), an appropriate stent for each stenosis will be implanted and then dilated using a balloon catheter.

Trial Locations (1)

70800

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT02310191 - Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting | Biotech Hunter | Biotech Hunter